Jounce Therapeutics $64.7 million follow-on offering
We advised the underwriters on the equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Shake Shack $250 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A convertible notes offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering
Adtalem $800 million notes offering
We advised the initial purchasers on the high-yield notes offering
Ayala Pharmaceuticals $25 million private placement
We advised the placement agent on the private placement of stock and warrants
loanDepot $62 million IPO
The shares are listed on the New York Stock Exchange
Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Applied Genetic Technologies follow-on offering
We advised the underwriters on the equity offering
Precigen $129 million common stock offering
We advised the underwriters in connection with the SEC-registered equity offering